R6	Anaphora Anaphor:T164 Antecedent:T125
R7	Anaphora Anaphor:T170 Antecedent:T168
R8	Anaphora Anaphor:T171 Antecedent:T170
T27	Drug 2200 2212	INDOCIN I.V.
T2	Drug_Class 2478 2494	nephrotoxic drug
T14	Drug_Class 4312 4382	medications that rely on adequate renal function for their elimination
T15	Drug 4236 4248	INDOCIN I.V.
T65	Drug 4566 4578	indomethacin
T62	Drug 4409 4418	digitalis
T69	Drug_Class 4884 4899	aminoglycosides
T25	Drug 4837 4845	amikacin
T22	Drug 4823 4833	gentamicin
T68	Drug 4784 4796	INDOCIN I.V.
T70	Drug 4942 4954	indomethacin
T72	Drug 4991 5001	furosemide
T74	Drug_Class 5081 5118	non-steroidal anti-inflammatory drugs
T66	Drug 5317 5329	INDOCIN I.V.
T67	Drug 5334 5344	furosemide
T89	Drug 5810 5822	indomethacin
T90	Drug_Class 5835 5849	anticoagulants
T93	Drug_Class 5996 6010	anticoagulants
T94	Drug 6015 6027	INDOCIN I.V.
T96	Drug 6061 6073	INDOCIN I.V.
T97	Drug_Class 6078 6092	anticoagulants
T98	Drug_Class 6203 6208	NSAID
T99	Drug_Class 6216 6229	ACE inhibitor
T100	Drug_Class 6233 6258	angiotensin II antagonist
T102	Drug 82 94	INDOCIN I.V.
T103	Drug 1589 1601	INDOCIN I.V.
T104	Drug 1701 1713	INDOCIN I.V.
T105	Drug 1789 1801	INDOCIN I.V.
T106	Drug 2099 2111	INDOCIN I.V.
T107	Drug 2586 2598	INDOCIN I.V.
T108	Drug 2684 2696	INDOCIN I.V.
T109	Drug 2966 2978	INDOCIN I.V.
T110	Drug 3687 3699	INDOCIN I.V.
T111	Drug 3724 3736	INDOCIN I.V.
T112	Drug 5205 5217	INDOCIN I.V.
T113	Drug 5244 5256	INDOCIN I.V.
T114	Drug 5498 5510	INDOCIN I.V.
T115	Drug 5644 5656	INDOCIN I.V.
T116	Drug 4644 4653	digitalis
T117	Drug 4698 4707	digitalis
T118	Drug_Class 5789 5803	anticoagulants
T119	Drug 46 58	indomethacin
T120	Drug 863 875	indomethacin
T121	Drug 1056 1068	indomethacin
T122	Drug 1194 1206	indomethacin
T123	Drug 1274 1286	Indomethacin
T124	Drug 1437 1449	indomethacin
T125	Drug 3139 3151	Indomethacin
T126	Drug 3446 3458	indomethacin
T127	Drug 3550 3562	Indomethacin
T128	Drug 3839 3851	indomethacin
T129	Drug 5713 5725	Indomethacin
T130	Drug 6425 6437	indomethacin
T131	Drug 5261 5271	furosemide
T132	Drug 5570 5580	furosemide
T3	Drug 3130 3137	INDOCIN
T214	SPAN 4178 4195	Drug Interactions
T136	ZeroArticleNP 0 10	Drug Label
T137	ZeroArticleNP 15 33	drug brand Indocin
T138	DefiniteNP 544 565	the ductus arteriosus
T139	DefiniteNP 705 714	the aorta
T140	DefiniteNP 759 782	the collaborative study
T141	DemonstrativeNP 838 852	those neonates
T142	DemonstrativeNP 884 898	those neonates
T143	DefiniteNP 990 999	the stool
T144	DemonstrativeNP 1028 1042	those neonates
T145	IndefiniteNP 1362 1384	an increased incidence
T146	DefiniteNP 1484 1497	the potential
T147	DefiniteNP 1558 1585	the large multicenter study
T148	DefiniteNP 1631 1644	the incidence
T149	DefiniteNP 1751 1771	the control neonates
T150	DemonstrativeNP 2009 2022	These effects
T151	ZeroArticleNP 2086 2093	therapy
T152	IndefiniteNP 2309 2325	other conditions
T153	IndefiniteNP 2410 2419	any cause
T154	IndefiniteNP 2474 2494	any nephrotoxic drug
T155	DefiniteNP 2641 2665	the urine output returns
T156	IndefiniteNP 2576 2582	a dose
T157	IndefiniteNP 2749 2765	a greater extent
T158	IndefiniteNP 2807 2830	a significant reduction
T159	ZeroArticleNP 2953 2960	therapy
T160	ZeroArticleNP 3055 3072	Drug Interactions
T161	DefiniteNP 3162 3177	the usual signs
T162	DefiniteNP 3216 3229	the physician
T163	DefiniteNP 3253 3262	the alert
T164	DefiniteNP 3287 3295	the drug
T165	DefiniteNP 3315 3327	the presence
T166	DefiniteNP 3637 3648	the neonate
T167	DefiniteNP 3904 3925	the ductus arteriosus
T168	ZeroArticleNP 3839 3859	indomethacin therapy
T169	DefiniteNP 3971 3984	the tenth day
T170	DefiniteNP 4046 4054	The drug
T171	DefiniteNP 4135 4147	the solution
T172	PossessivePronoun 4306 4382	those medications that rely on adequate renal function for their elimination
T173	DefiniteNP 4392 4405	the half-life
T174	DefiniteNP 4580 4591	the neonate
T175	DemonstrativeNP 4878 4899	these aminoglycosides
T176	DefiniteNP 4965 4987	the natriuretic effect
T177	ZeroArticleNP 4929 4936	Therapy
T178	DemonstrativeNP 5003 5016	This response
T179	ZeroArticleNP 5081 5118	non-steroidal anti-inflammatory drugs
T180	IndefiniteNP 5123 5130	a study
T181	DistributiveNP 5198 5217	either INDOCIN I.V.
T182	IndefiniteNP 5227 5240	a combination
T183	DefiniteNP 5533 5541	the data
T184	DefiniteNP 5618 5638	the premature infant
T185	DemonstrativeNP 5521 5531	this study
T186	ZeroArticleNP 5557 5564	therapy
T187	DefiniteNP 5670 5683	the treatment
T188	DefiniteNP 5753 5776	the hypoprothrombinemia
T189	ZeroArticleNP 5789 5803	anticoagulants
T190	ZeroArticleNP 5835 5849	anticoagulants
T191	ZeroArticleNP 5996 6010	anticoagulants
T192	ZeroArticleNP 6078 6092	anticoagulants
T193	DefiniteNP 6175 6196	the co-administration
T194	IndefiniteNP 6128 6141	some patients
T195	IndefiniteNP 6200 6208	an NSAID
T196	IndefiniteNP 6213 6229	an ACE inhibitor
T197	ZeroArticleNP 6233 6258	angiotensin II antagonist
T198	DefiniteNP 6465 6484	the last three days
T199	IndefiniteNP 6505 6515	a decrease
T200	IndefiniteNP 6544 6574	some maternal and fetal deaths
T201	DefiniteNP 6623 6639	the diencephalon
T202	DefiniteNP 6643 6664	the live-born fetuses
T203	IndefiniteNP 6576 6598	An increased incidence
T204	DefiniteNP 6758 6776	the control groups
T205	DistributivePronoun 6903 6909	either
T206	DefiniteNP 6824 6844	the first three days
T207	IndefiniteNP 6867 6878	an increase
T208	DistributiveNP 6903 6920	either dose level
T209	DistributivePronoun 7070 7074	both
T210	DefiniteNP 6982 7000	the last trimester
T211	DefiniteNP 7171 7183	the syndrome
T212	DefiniteNP 7224 7235	the neonate
T213	DemonstrativeNP 7123 7137	These findings
